Wikidata

(Q61934028)

English

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

clinical trial

In more languages

Statements

title
A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist Casopitant (GW679769) in Combination With Ondansetron and Dexamethasone for the Prevention of Nausea (English)
0 references
medical condition
vomiting
0 references
nausea
0 references
sponsor
GSK
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Czech Republic
0 references
Denmark
0 references
Estonia
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Republic of Ireland
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Mexico
0 references
Pakistan
0 references
Peru
0 references
Philippines
0 references
Poland
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
Thailand
0 references
United Kingdom
0 references
start time
July 2006
0 references
end time
October 2007
0 references
number of participants
1,840
0 references
research intervention
casopitant
0 references
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
ondansetron
0 references
research site
GSK
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61934028&oldid=2104526390"